| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $62.50M | - | |
| Dir | 469.9K | $3.32M | - | |
| Dir | 36.0K | $254.2K | - | |
| Dir | 36.0K | $254.2K | - | |
| Dir | 36.0K | $254.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Gould Robert J85 | Director | Sell | 15,000 | $11.87 | $178,089.00 | -3.1% | -26.4% | - | |
| Dec 15, 2025 | Oltmans Curtis Gale | Chief Legal Officer | Sell | 3,452 | $12.92 | $44,599.84 | -25.2% | -42.4% | - | |
| Dec 8, 2025 | Ra Capital Management, L.P.52 | 10% Owner | Sell | 4,175,139 | $13.98 | $58,377,021.32 | -16.6% | -39.0% | - | |
| Nov 19, 2025 | Gould Robert J85 | Director | Sell | 15,000 | $11.03 | $165,495.00 | -3.0% | -7.4% | - | |
| May 8, 2025 | Tourangeau Greg54 | Principal Accounting Officer | Sell | 498 | $5.06 | $2,519.88 | -3.4% | +28.3% | - | |
| May 7, 2024 | Tourangeau Greg54 | Principal Accounting Officer | Sell | 236 | $7.76 | $1,831.36 | -2.0% | +12.2% | -32.8% | |
| Mar 8, 2024 | Tourangeau Greg54 | Vice President, Finance | Sell | 4,884 | $11.72 | $57,218.50 | -29.3% | -24.5% | -71.7% | |
| Mar 4, 2024 | Sapir Alex | See Remarks | Buy | 43,360 | $11.35 | $492,027.60 | New | -27.8% | -71.1% | |
| May 10, 2023 | Tourangeau Greg54 | Principal Accounting Officer | Sell | 210 | $3.31 | $695.10 | -1.3% | +23.2% | +129.4% | |
| Jan 20, 2023 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 1,923,076 | $13.00 | $24,999,988.00 | +19.9% | -80.4% | -45.2% |